Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)
Germany · Delayed Price · Currency is EUR 0.9100
-0.0050 (-0.55%)
At close: Jan 30, 2026
FRA:TQR Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 515.36 | 500.28 | 540.39 | 645.88 | 607.84 | 542.46 |
Depreciation & Amortization | 88.28 | 85.98 | 80.45 | 73.6 | 69.02 | 78.09 |
Other Amortization | 4.99 | 2.14 | 2.06 | 1.87 | 0.96 | - |
Loss (Gain) From Sale of Assets | -2.41 | -2.41 | 0.38 | -0.03 | 0.44 | 2.12 |
Asset Writedown & Restructuring Costs | - | - | - | 0.05 | - | - |
Loss (Gain) From Sale of Investments | - | - | -2.88 | - | - | - |
Loss (Gain) on Equity Investments | -2.06 | -2.06 | 3.26 | 1.54 | -0.26 | 0.86 |
Provision & Write-off of Bad Debts | 1.95 | 1.95 | 21.19 | 6.48 | 7.52 | 3.33 |
Other Operating Activities | 735.34 | -28.78 | -149.7 | 144.97 | 31.62 | -88.85 |
Change in Accounts Receivable | -116.75 | -116.75 | 492.15 | -434.16 | 23.19 | -219.54 |
Change in Inventory | -584.26 | -584.26 | -543.6 | -47 | 64.96 | -168.75 |
Change in Accounts Payable | -73.35 | -73.35 | 17.12 | 154.24 | -28.1 | -33.66 |
Operating Cash Flow | 567.1 | -217.25 | 460.83 | 547.44 | 777.17 | 116.05 |
Operating Cash Flow Growth | - | - | -15.82% | -29.56% | 569.66% | -78.94% |
Capital Expenditures | -48.35 | -43.17 | -21.87 | -38.51 | -23.43 | -12.88 |
Sale of Property, Plant & Equipment | 0 | 0 | 0.06 | 0.13 | 0.02 | 0.03 |
Cash Acquisitions | - | - | - | -3.26 | -13.55 | - |
Investment in Securities | -168.34 | 1,332 | -1,126 | 362.27 | -234 | 490.56 |
Other Investing Activities | 63.02 | 65.81 | 69.17 | 14.79 | 5.22 | 29.02 |
Investing Cash Flow | -153.66 | 1,355 | -1,079 | 335.41 | -265.73 | 506.73 |
Long-Term Debt Issued | - | - | - | - | 0.39 | 1.39 |
Long-Term Debt Repaid | - | -63.97 | -58.73 | -56.48 | -50.66 | -46.78 |
Net Debt Issued (Repaid) | -63.7 | -63.97 | -58.73 | -56.48 | -50.28 | -45.39 |
Common Dividends Paid | -292.99 | -276.24 | -276.24 | -234.39 | -200.9 | -192.54 |
Other Financing Activities | 3.55 | -15.09 | -37.21 | -35.28 | -27.47 | -26.37 |
Financing Cash Flow | -353.14 | -355.3 | -372.18 | -535.42 | -278.65 | -264.3 |
Foreign Exchange Rate Adjustments | 7.16 | -9.04 | -1.28 | -16.78 | 1.48 | 10.85 |
Net Cash Flow | 67.46 | 773.26 | -991.15 | 330.66 | 234.26 | 369.33 |
Free Cash Flow | 518.75 | -260.42 | 438.97 | 508.94 | 753.74 | 103.17 |
Free Cash Flow Growth | - | - | -13.75% | -32.48% | 630.55% | -80.68% |
Free Cash Flow Margin | 30.36% | -16.16% | 28.79% | 29.40% | 48.44% | 7.84% |
Free Cash Flow Per Share | 0.62 | -0.31 | 0.52 | 0.61 | 0.90 | 0.12 |
Cash Interest Paid | 6.64 | 6.48 | 5.98 | 4.66 | 4.71 | 4.3 |
Cash Income Tax Paid | 108.42 | 108.42 | 231.04 | 19.16 | 137.84 | 211.54 |
Levered Free Cash Flow | 413.57 | -382.46 | 318.64 | 315.94 | 593.34 | -36.95 |
Unlevered Free Cash Flow | 417.72 | -378.41 | 322.38 | 318.85 | 596.28 | -34.26 |
Change in Working Capital | -774.35 | -774.35 | -34.32 | -326.91 | 60.04 | -421.95 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.